Drug intelligence / Profile preview

Zingerone

Development stage
Preclinical
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral
01

Overview

Zingerone is a naturally occurring phenolic alkanone, chemically known as vanillyl acetone, and is one of the active components isolated from the rhizome of Zingiber officinale (ginger)[1][3][4]. It is primarily present in dry ginger, with its concentration increasing upon cooking or drying due to conversion from gingerol via a retroaldol reaction[1][4]. Zingerone exhibits a wide range of pharmacological activities including antioxidant, anti-inflammatory, anticancer, antimicrobial, antidiabetic, antilipolytic, antidiarrhoeic, and antispasmodic effects[1][3][5]. Mechanistically, zingerone acts as an antioxidant by scavenging free radicals and exerts anti-inflammatory effects through suppression of Nuclear factor kappa B (NF-κB) activation and inhibition of pro-inflammatory cytokines such as IL-1β and TNF-α[3][8]. It also demonstrates radioprotective properties and has been shown to inhibit tumor progression by suppressing matrix metalloproteinases (MMP-2 and MMP-9)[3]. In animal models it alleviates inflammatory pain by modulating synaptic transmission in neurons[6], protects against chemically induced hepatotoxicity[5], reduces oxidative stress markers in diabetes models[5], and suppresses LPS-induced liver inflammation via Toll-like receptor 4 (TLR4)/NF-κB signaling pathway inhibition[8].

Other names
vanillyl acetone
02

Targets

MMP2 (Matrix metalloproteinase-2)MMP9 (Matrix metalloproteinase-9)NF-κBTLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on Zingerone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zingerone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call